Physician profile
Mark J Langhans
NPI 1700805579
$7,302.83
in general payments reported to CMS, 2019-2025
7 companies · $63.79 in 2025
The $63.79 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,822 · 2020: $73.31 · 2021: $1,452 · 2023: $836 · 2024: $56.20 · 2025: $63.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $670 · Travel and Lodging: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $669.86 |
| Travel and Lodging | $286.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $4,407.68 | 2019-2021 | |
| Stryker Corporation | $1,646.47 | 2019-2023 | Inspace, Iconix |
| Smith+Nephew, INC. | $516.37 | 2023 | Novostitch, Acufex Meniscal Root Repair, Fast-Fix |
| Depuy Synthes Sales INC. | $463.33 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $177.60 | 2019-2024 | Comprehensive Shoulder System |
| Vertex Pharmaceuticals Incorporated | $63.79 | 2025 | |
| Bioventus LLC | $27.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Langhans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.